Literature DB >> 21320019

Identification of risk factors for septic peritonitis and failure to survive following gastrointestinal surgery in dogs.

Janet A Grimes1, Chad W Schmiedt, Karen K Cornell, Mary Ann G Radlinksy.   

Abstract

OBJECTIVE: To identify risk factors for failure to survive and development of septic peritonitis following full-thickness gastrointestinal incision in dogs. Design-Retrospective cohort study. ANIMALS: Dogs that underwent gastrointestinal surgery from 1998 through 2007 at the University of Georgia Veterinary Teaching Hospital. Procedures-Medical records of dogs undergoing a full-thickness gastrointestinal incision were reviewed, and information regarding dog history, clinicopathologic findings, surgery characteristics, and outcome was collected.
RESULTS: Records for 197 dogs (225 surgeries) were evaluated. In 35 (16%) surgeries, the dogs died prior to hospital discharge. After 28 (12%) surgeries, dogs developed septic peritonitis. For 45 (20%) surgeries, dogs had preoperative septic peritonitis; of those, approximately a third resulted in continued septic peritonitis (17/45; 38%) or death (15/45; 33%). Of the 180 surgeries performed in dogs lacking preoperative septic peritonitis, 11 (6%) resulted in development of septic peritonitis and 20 (11 %) resulted in death. When all surgeries were considered, common risk factors for development of septic peritonitis included preoperative septic peritonitis, low preoperative serum albumin and plasma protein concentrations, and intraoperative hypotension. Presence of a foreign body was a protective factor. CONCLUSIONS AND CLINICAL RELEVANCE: Multiple factors were associated with failure to survive and development of septic peritonitis after gastrointestinal surgery in dogs. Aggressive perioperative attempts to increase protein concentrations and intraoperative surgical strategies to decrease the chance of a poor outcome may be indicated in dogs with risk factors identified in this study.

Entities:  

Mesh:

Year:  2011        PMID: 21320019     DOI: 10.2460/javma.238.4.486

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  The effect of time until surgical intervention on survival in dogs with secondary septic peritonitis.

Authors:  Maxwell Bush; Margaret A Carno; Lindsay St Germaine; Daniel E Hoffmann
Journal:  Can Vet J       Date:  2016-12       Impact factor: 1.008

2.  Comparison of perioperative and short-term postoperative complications of gastrointestinal biopsies via laparoscopic-assisted technique versus laparotomy.

Authors:  Laura Mitterman; Jennifer Bonczynski; Kendra Hearon; Laura E Selmic
Journal:  Can Vet J       Date:  2016-04       Impact factor: 1.008

3.  A retrospective analysis of 25% human serum albumin supplementation in hypoalbuminemic dogs with septic peritonitis.

Authors:  Farrah B Horowitz; Robyn L Read; Lisa L Powell
Journal:  Can Vet J       Date:  2015-06       Impact factor: 1.008

4.  Clinical findings and patient outcomes following surgical treatment of chronic gastrointestinal foreign body obstructions in dogs and cats: 72 cases (2010-2020).

Authors:  Tiffany Kan; Rebecka S Hess; Dana L Clarke
Journal:  Can J Vet Res       Date:  2022-10       Impact factor: 0.897

5.  Benefits of Intraluminal Agarose Stents during End-to-End Intestinal Anastomosis in New Zealand White Rabbits.

Authors:  Wen-Yao Kuo; Hsiao-Chun Huang; Shih-Wei Huang; Kuan-Hua Yu; Feng-Pang Cheng; Jiann-Hsiung Wang; Jui-Te Wu
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

6.  Evaluation of short-term loop colostomy in dogs using conventional and supporting subcutaneous silicone drain techniques.

Authors:  Alaa Samy; Abdelnasser Abdalla; Awad Rizk
Journal:  J Adv Vet Anim Res       Date:  2020-11-08

7.  Prevalence, outcome and risk factors for postoperative pyothorax in 232 dogs undergoing thoracic surgery.

Authors:  L B Meakin; L K Salonen; S J Baines; D J Brockman; S P Gregory; Z J Halfacree; V J Lipscomb; K C Lee
Journal:  J Small Anim Pract       Date:  2013-04-15       Impact factor: 1.522

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.